IC
QTTB icon

Ikarian Capital’s Q32 Bio QTTB Stock Holding History

Ikarian Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
+200,000
New +$1.67M 0.27% 78
2021
Q1 		– Sell
-5,556
Closed -$1.13M – 335
2020
Q4 		$1.13M Buy
+5,556
New +$1.07M 0.05% 173

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ikarian Capital's QTTB Position: Q2 2026 in Review

Ikarian Capital opened a new position in Q32 Bio (QTTB) in Q2 2026: 430,000 shares worth $5.48M. The stake represents 0.59% of the portfolio and ranks #51 among its holdings. This is a return to the name: Ikarian Capital previously reported a position in QTTB as recently as Q2 2024.

Ikarian Capital first reported a position in QTTB in Q1 2024 and has held it in 3 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Ikarian Capital held 430,000 shares of Q32 Bio worth $5.48M as of Q2 2026.
  • Q32 Bio was a new Ikarian Capital position in Q2 2026.
  • Q32 Bio made up 0.59% of Ikarian Capital's portfolio in Q2 2026, its #51 holding.
  • Ikarian Capital first reported a position in Q32 Bio in Q1 2024 and has held it in 3 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.